- Home
- AUDC vs BNTC Comparison
AUDC vs BNTC Comparison
Compare AUDC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- BNTC
- Stock Information
- Founded
- AUDC 1992
- BNTC 1995
- Country
- AUDC Israel
- BNTC United States
- Employees
- AUDC N/A
- BNTC N/A
- Industry
- AUDC Telecommunications Equipment
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- AUDC Utilities
- BNTC Health Care
- Exchange
- AUDC Nasdaq
- BNTC Nasdaq
- Market Cap
- AUDC 299.7M
- BNTC 339.8M
- IPO Year
- AUDC 1999
- BNTC N/A
- Fundamental
- Price
- AUDC $10.14
- BNTC $15.66
- Analyst Decision
- AUDC Buy
- BNTC Strong Buy
- Analyst Count
- AUDC 2
- BNTC 7
- Target Price
- AUDC $11.25
- BNTC $24.43
- AVG Volume (30 Days)
- AUDC 78.0K
- BNTC 37.6K
- Earning Date
- AUDC 05-06-2025
- BNTC 05-12-2025
- Dividend Yield
- AUDC 1.77%
- BNTC N/A
- EPS Growth
- AUDC 78.82
- BNTC N/A
- EPS
- AUDC 0.50
- BNTC N/A
- Revenue
- AUDC $242,176,000.00
- BNTC N/A
- Revenue This Year
- AUDC $5.11
- BNTC N/A
- Revenue Next Year
- AUDC $3.79
- BNTC N/A
- P/E Ratio
- AUDC $20.42
- BNTC N/A
- Revenue Growth
- AUDC N/A
- BNTC N/A
- 52 Week Low
- AUDC $7.70
- BNTC $4.75
- 52 Week High
- AUDC $13.71
- BNTC $15.97
- Technical
- Relative Strength Index (RSI)
- AUDC 37.72
- BNTC 73.53
- Support Level
- AUDC $10.08
- BNTC $11.99
- Resistance Level
- AUDC $10.69
- BNTC $15.97
- Average True Range (ATR)
- AUDC 0.31
- BNTC 1.03
- MACD
- AUDC -0.07
- BNTC 0.33
- Stochastic Oscillator
- AUDC 6.12
- BNTC 93.76
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.